Tirzepatide lowered risk of worsening heart failure and CVD death for obese adults
byAmerican Heart AssociationCredit: Unsplash/CC0 Public DomainIn the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking tirzepatide for
Updated on: November 26,2024
0

Tirzepatide lowered risk of worsening heart failure and CVD death for obese adults
byAmerican Heart AssociationCredit: Unsplash/CC0 Public DomainIn the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking tirzepatide for
Updated on:November 26,2024
0
